Prakash Lingasamy

ORCID: 0000-0002-8826-4531 · 3 papers in corpus
2025
Scientific reports ·doi:10.1038/s41598-025-11299-x

To improve the precision and selectivity of anticancer therapies, affinity ligands targeting molecules of the malignancy-associated vascular signature are used. One such target is Fibronectin Extra Domain-B (Fn-EDB), an oncofetal splice var…

2023
Seminars in reproductive medicine ·doi:10.1055/s-0043-1778017

The dynamic interplay between the immunome and microbiome in reproductive health is a complex and rapidly advancing research field, holding tremendously vast possibilities for the development of reproductive medicine. This immunome-microbio…

article 2021
Nanomaterials (Basel, Switzerland) ·doi:10.3390/nano11123257

The current diagnostic and therapeutic strategies for endometriosis are limited. Although endometriosis is a benign condition, some of its traits, such as increased cell invasion, migration, tissue inflammation, and angiogenesis are similar…